{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:03:58Z","timestamp":1784707438784,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Biktarvy, a second-generation integrase strand-transfer inhibitor, is approved for treating human immunodeficiency virus (HIV) in patients with no known resistance to its components. This study compared adverse events (AEs) associated with biktarvy based on data from the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database and real-world evidence from a hospital setting to inform clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>AE reports were extracted from the FAERS database and our hospital\u2019s internal records. The Reporting Odds Ratio (ROR) and the Bayesian Confidence Propagation Neural Network (BCPNN) were used to assess the reporting of AEs associated with biktarvy. A positive signal was defined as meeting all of the following criteria: case number \u2265 3, ROR 95% confidence interval lower limit &amp;gt; 1.0, (IC-2SD) &amp;gt; 0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 10,424 AE reports were retrieved (6,850 from FAERS and 3,574 from hospital data). Males and patients aged 18\u201364.9 years accounted for a larger proportion of AE reports in terms of raw counts. Overall, 343 unique AEs met the positive signal threshold (263 from FAERS and 80 from the hospital). Hospital data identified signals including elevated urine vitamin C, triglycerides, and uric acid. FAERS data revealed signals for cerebrovascular accident, myocardial infarction, and cardiomegaly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hospital data indicated a risk of eye disorders and certain abnormal investigation findings not mentioned in the package insert, while the FAERS data pointed to a potential risk domain of vascular diseases such as cerebrovascular accident and myocardial infarction. Our study provides evidence for the use of biktarvy in the treatment of HIV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1837474","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:35:39Z","timestamp":1782102939000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative safety profile of biktarvy: insights from a clinical cohort and the FAERS database"],"prefix":"10.3389","volume":"17","author":[{"given":"Xinmei","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangchuan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Army Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.14423\/smj.0000000000000500","article-title":"Determinants of elevated alkaline phosphatase in patients infected with HIV","volume":"109","author":"Alemu","year":"2016","journal-title":"South Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/cir.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/ijstd.IJSTD_58_16","article-title":"Study of mucocutaneous manifestations of HIV and its relation to total lymphocyte count","volume":"41","author":"Ashwini","year":"2020","journal-title":"Indian J. Sex. Transm. Dis. AIDS"},{"key":"B4","first-page":"399","article-title":"Posterior segment ocular manifestations of HIV\/AIDS patients","volume":"7","author":"Chiotan","year":"2014","journal-title":"J. Med. Life"},{"key":"B5","doi-asserted-by":"publisher","first-page":"115862","DOI":"10.1016\/j.bcp.2023.115862","article-title":"Biktarvy for the treatment of HIV infection: progress and prospects","volume":"217","author":"De Clercq","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1007\/s00417-022-05660-3","article-title":"Temporal trends in ocular manifestations of HIV\/AIDS patients in the past 18 years in a tertiary hospital in China","volume":"260","author":"Di","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/cid\/ciad333","article-title":"Vitamin C urinary loss and deficiency in human immunodeficiency virus (HIV): cross-Sectional study of vitamin C renal leak in women with HIV","volume":"77","author":"Ebenuwa","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev-virology-040323-082822","article-title":"Regulation of immune homeostasis, inflammation, and HIV persistence by the microbiome, short-chain fatty acids, and bile acids","volume":"10","author":"Enriquez","year":"2023","journal-title":"Annu. Rev. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/01.aids.0000060358.78202.c1","article-title":"Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-M\u00f8ller","year":"2003","journal-title":"Aids"},{"key":"B10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1570162x21666221222104349","article-title":"Better predictive value of lymphocyte count and hemoglobin for CD4 level of HIV patients","volume":"21","author":"Gao","year":"2023","journal-title":"Curr. HIV Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.clinthera.2025.12.001","article-title":"Pharmacovigilance assessment of PD-1 antibody therapy in head and neck cancer: risk factor analysis using FAERS database","volume":"48","author":"Gao","year":"2026","journal-title":"Clin. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1365-2036.2012.05093.x","article-title":"Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B","volume":"35","author":"Gara","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"106020","DOI":"10.1016\/j.antiviral.2024.106020","article-title":"Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction","volume":"231","author":"Garc\u00eda-Mart\u00ednez","year":"2024","journal-title":"Antivir. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1563566","DOI":"10.3389\/fphar.2025.1563566","article-title":"Correlation between UGT1A1 polymorphism and efficacy and toxicity of Irinotecan in Chinese cancer patients","volume":"16","author":"Geng","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.pathol.1.110304.100100","article-title":"Inflammation and atherosclerosis","volume":"1","author":"Hansson","year":"2006","journal-title":"Annu. Rev. Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40264-014-0150-2","article-title":"The Weber effect and the United States food and drug Administration's Adverse Event Reporting system (FAERS): analysis of sixty-two drugs approved from 2006 to 2010","volume":"37","author":"Hoffman","year":"2014","journal-title":"Drug Saf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jgar.2023.10.012","article-title":"Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir\/emtricitabine\/tenofovir alafenamide","volume":"36","author":"Hsu","year":"2024","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"B19","doi-asserted-by":"publisher","first-page":"ijerph13010030","DOI":"10.3390\/ijerph13010030","article-title":"Characterizing the HIV\/AIDS epidemic in the United States and China","volume":"13","author":"Huang","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00406-023-01732-5","article-title":"The correlation of Esketamine with specific adverse events: a deep dive into the FAERS database","volume":"275","author":"Jiang","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40545-023-00559-8","article-title":"Access to a novel first-line single-tablet HIV antiretroviral regimen in affordable care act marketplace plans, 2018-2020","volume":"16","author":"Khazanchi","year":"2023","journal-title":"J. Pharm. Policy Pract."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1001\/archopht.1997.01100160461014","article-title":"HIV and AIDS and the eye in developing countries: a review","volume":"115","author":"Lewallen","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"23259582221140208","DOI":"10.1177\/23259582221140208","article-title":"Real world data on forgiveness to uncomplete adherence to Bictegravir\/emtricitabine\/tenofovir alafenamide","volume":"21","author":"Maggiolo","year":"2022","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12886-016-0310-5","article-title":"Ocular complications in HIV positive patients on antiretroviral therapy in Ghana","volume":"16","author":"Martin-Odoom","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0462","DOI":"10.1097\/md.0000000000010462","article-title":"Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis","volume":"97","author":"Mohr","year":"2018","journal-title":"Med. Baltim."},{"key":"B26","doi-asserted-by":"publisher","first-page":"758682","DOI":"10.1155\/2013\/758682","article-title":"The role of red blood cells in enhancing or preventing HIV infection and other diseases","volume":"2013","author":"Motswaledi","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12981-023-00501-7","article-title":"A possible case of bictegravir-associated severe unconjugated hyperbilirubinemia","volume":"20","author":"Parmar","year":"2023","journal-title":"AIDS Res. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2018.03.031","article-title":"Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy","volume":"272","author":"Pirro","year":"2018","journal-title":"Atherosclerosis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/cpt.3701","article-title":"FDA adverse event reporting system (FAERS) essentials: a guide to understanding, applying, and interpreting adverse event data reported to FAERS","volume":"118","author":"Potter","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3851\/imp3058","article-title":"Elvitegravir\/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution?","volume":"22","author":"Riva","year":"2017","journal-title":"Antivir. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/cid\/ciaf077","article-title":"Doravirine\/Islatravir (100\/0.75 mg) once-daily compared with Bictegravir\/Emtricitabine\/Tenofovir Alafenamide as initial HIV-1 treatment: 48-Week results from a phase 3, randomized, controlled, Double-Blind, noninferiority trial","volume":"81","author":"Rockstroh","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the international Antiviral Society-USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"Jama"},{"key":"B33","doi-asserted-by":"publisher","first-page":"ofz414","DOI":"10.1093\/ofid\/ofz414","article-title":"Changes in body mass index and atherosclerotic disease risk Score after switching from tenofovir disoproxil fumarate to tenofovir alafenamide","volume":"6","author":"Schafer","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-234483","article-title":"Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis","volume":"13","author":"Simeni Njonnou","year":"2020","journal-title":"BMJ Case Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e62604","DOI":"10.7759\/cureus.62604","article-title":"Severe lactic acidosis due to inappropriate use of biktarvy in a patient with AIDS","volume":"16","author":"Strike","year":"2024","journal-title":"Cureus"},{"key":"B36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-2008-1035190","article-title":"Increased possibility for HIV-Associated retinal microangiopathy syndrome in patients with concomitant hepatitis C infection","volume":"208","author":"Thierfelder","year":"1996","journal-title":"Klin. Monbl Augenheilkd"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1097\/cm9.0000000000002907","article-title":"Efficacy and safety profiles of dolutegravir plus lamivudine vs. Bictegravir\/Emtricitabine\/Tenofovir alafenamide in therapy-na\u00efve adults with HIV-1","volume":"136","author":"Wei","year":"2023","journal-title":"Chin. Med. J. Engl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0313338","DOI":"10.1371\/journal.pone.0313338","article-title":"Bictegravir\/Emtricitabine\/Tenofovir alafenamide (B\/F\/TAF) in treatment-na\u00efve and treatment-experienced people with HIV: 12-month virologic effectiveness and safety outcomes in the BICSTaR Japan cohort","volume":"20","author":"Yokomaku","year":"2025","journal-title":"PLoS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2024-vol4","DOI":"10.69097\/41-04-2024-03","article-title":"Impact of serum phosphorus on hemoglobin: a literature review","volume":"41","author":"Zirino","year":"2024","journal-title":"G. Ital. Nefrol."}],"updated-by":[{"DOI":"10.3389\/fphar.2026.1934013","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1837474\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:51:24Z","timestamp":1784706684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1837474\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":40,"alternative-id":["10.3389\/fphar.2026.1837474"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1837474","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1837474"}}